Liposomal bupivacaine: a delay rather than elimination of rebound pain in mouse postoperative model

Hao Wu1, Jiayu Jin2, Di Zhou2

  • 1Department of Anesthesiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, China.

BMC Anesthesiology
|November 27, 2025
PubMed
Abstract

Insights

Liposomal bupivacaine (LB) delays, but does not prevent, rebound pain after nerve blocks. This study found LB extended analgesia but caused delayed pain and increased nerve inflammation in mice.

Area of Science:

  • Anesthesiology
  • Pain Management
  • Pharmacology

Background:

  • Prolonged analgesia with liposomal bupivacaine (LB) is established, but its effect on rebound pain remains unclear.
  • This study investigates if LB prevents or merely delays rebound pain following peripheral nerve blockade.

Purpose of the Study:

  • To determine the effect of LB on rebound pain in a mouse model.
  • To assess if nerve block resolution with LB results in pain exceeding unblocked controls.

Main Methods:

  • Nerve stimulator-guided vs. landmark-based sciatic and femoral nerve blockade success rates were compared using methylene blue staining.
  • Rebound pain after LB administration was assessed using von Frey and Hargreaves tests.
  • Histological analyses examined perineural inflammation and Wallerian degeneration.

Main Results:

  • Nerve stimulator guidance demonstrated high block success rates (93.3% sciatic, 73.3% femoral).
  • LB extended thermal (24h) and mechanical (36h) analgesia.
  • Transient thermal rebound pain occurred at 48h; no mechanical rebound was observed. Increased Wallerian degeneration and nerve inflammation were noted in the LB group.

Conclusions:

  • Liposomal bupivacaine delays the onset of rebound pain rather than preventing it.
  • LB administration in a mouse model resulted in delayed pain and increased nerve inflammation.

Related Concept Videos

Local Anesthetics: Pharmacokinetics01:13

Local Anesthetics: Pharmacokinetics

The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
1.2K
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
1.1K
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
674
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
892
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.3K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K